| Literature DB >> 22964086 |
David W Salzman1, Joanne B Weidhaas.
Abstract
MicroRNAs are master regulators of gene expression and control many biological pathways such as cell growth, differentiation and apoptosis. Deregulation of microRNA expression and activity results in a myriad of diseases including cancer. Recently, several reports have indicated that single nucleotide polymorphisms (SNPs) in microRNAs and microRNA-target sites impact microRNA biology and associate with cancer risk, treatment response and outcome. In this review we will describe these findings and discuss the possible future of utilizing these SNPs as diagnostic and prognostic markers in the clinic.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22964086 PMCID: PMC3546232 DOI: 10.1016/j.pharmthera.2012.08.016
Source DB: PubMed Journal: Pharmacol Ther ISSN: 0163-7258 Impact factor: 12.310